Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0146 | 0.1413 | 0.1413 |
Toxoplasma gondii | hypothetical protein | 0.0115 | 0.0957 | 0.1225 |
Trichomonas vaginalis | type I geranylgeranyltransferase beta subunit, putative | 0.0578 | 0.7809 | 1 |
Trypanosoma cruzi | protein farnesyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3332 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0578 | 0.7809 | 0.9082 |
Loa Loa (eye worm) | acetyltransferase | 0.0146 | 0.1413 | 0.1413 |
Echinococcus granulosus | geranylgeranyl transferase type 2 subunit alpha | 0.0244 | 0.2865 | 0.2865 |
Mycobacterium ulcerans | glyoxalase II, GloB | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0578 | 0.7809 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0178 | 0.1887 | 0.2195 |
Leishmania major | farnesyltransferase beta subunit | 0.0578 | 0.7809 | 1 |
Echinococcus granulosus | protein farnesyltransferase alpha subunit | 0.0359 | 0.4575 | 0.4575 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.1887 | 0.1887 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0631 | 0.8598 | 1 |
Plasmodium falciparum | protein farnesyltransferase subunit alpha | 0.0359 | 0.4575 | 0.5859 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0631 | 0.8598 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0359 | 0.4575 | 0.4575 |
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.0725 | 1 | 1 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.0725 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.0343 | 0.4327 | 0.5542 |
Mycobacterium ulcerans | hypothetical protein | 0.0051 | 0 | 0.5 |
Echinococcus multilocularis | protein farnesyltransferase subunit beta | 0.0578 | 0.7809 | 0.7809 |
Mycobacterium ulcerans | hypothetical protein | 0.0051 | 0 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.0051 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0244 | 0.2865 | 0.3669 |
Mycobacterium leprae | Beta-lactamase-like protein | 0.0051 | 0 | 0.5 |
Brugia malayi | Ets-domain containing protein | 0.0071 | 0.0292 | 0.0292 |
Trypanosoma brucei | protein farnesyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3332 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0071 | 0.0292 | 0.0292 |
Schistosoma mansoni | peptidylglycine monooxygenase | 0.0385 | 0.4958 | 0.4958 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.0578 | 0.7809 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0051 | 0 | 0.5 |
Toxoplasma gondii | Rab geranylgeranyl transferase type II beta subunit, putative | 0.0178 | 0.1887 | 0.2417 |
Plasmodium vivax | protein prenyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3669 |
Plasmodium vivax | conserved Plasmodium protein, unknown function | 0.0399 | 0.5167 | 0.6618 |
Loa Loa (eye worm) | prenyltransferase alpha subunit repeat containing protein | 0.0359 | 0.4575 | 0.4575 |
Plasmodium falciparum | geranylgeranyl transferase type2 beta subunit, putative | 0.0178 | 0.1887 | 0.2417 |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.0578 | 0.7809 | 0.7809 |
Trichomonas vaginalis | geranylgeranyl transferase type beta subunit, putative | 0.0578 | 0.7809 | 1 |
Trichomonas vaginalis | protein farnesyltransferase beta subunit, putative | 0.0178 | 0.1887 | 0.2417 |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.0343 | 0.4327 | 0.4327 |
Brugia malayi | Probable protein farnesyltransferase beta subunit, putative | 0.0178 | 0.1887 | 0.1887 |
Schistosoma mansoni | geranylgeranyl transferase type I beta subunit | 0.0343 | 0.4327 | 0.4327 |
Treponema pallidum | ribonuclease Z | 0.0051 | 0 | 0.5 |
Echinococcus multilocularis | Rab geranylgeranyltransferase, beta subunit | 0.0178 | 0.1887 | 0.1887 |
Echinococcus granulosus | protein farnesyltransferase subunit beta | 0.0578 | 0.7809 | 0.7809 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0146 | 0.1413 | 0.1413 |
Giardia lamblia | Rab geranylgeranyltransferase | 0.0359 | 0.4575 | 0.5859 |
Echinococcus multilocularis | protein prenyltransferase alpha subunit | 0.0244 | 0.2865 | 0.2865 |
Mycobacterium ulcerans | Zn-dependent glyoxylase | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0359 | 0.4575 | 0.5859 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0071 | 0.0292 | 0.0292 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0578 | 0.7809 | 1 |
Onchocerca volvulus | 0.0244 | 0.2865 | 1 | |
Plasmodium falciparum | geranylgeranyltransferase, putative | 0.0178 | 0.1887 | 0.2417 |
Trypanosoma cruzi | protein farnesyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3332 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0578 | 0.7809 | 1 |
Trypanosoma cruzi | Protein prenyltransferase alpha subunit repeat, putative | 0.0244 | 0.2865 | 0.3332 |
Trypanosoma brucei | protein farnesyltransferase beta subunit | 0.0578 | 0.7809 | 0.9082 |
Entamoeba histolytica | protein farnesyltransferase alpha subunit, putative | 0.0359 | 0.4575 | 0.5859 |
Trypanosoma brucei | Protein prenyltransferase alpha subunit repeat, putative | 0.0244 | 0.2865 | 0.3332 |
Loa Loa (eye worm) | prenyltransferase alpha subunit repeat containing protein | 0.0244 | 0.2865 | 0.2865 |
Brugia malayi | Protein prenyltransferase alpha subunit repeat containing protein | 0.0244 | 0.2865 | 0.2865 |
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0578 | 0.7809 | 1 |
Entamoeba histolytica | Rab geranylgeranyltransferase beta subunit, putative | 0.0178 | 0.1887 | 0.2417 |
Echinococcus multilocularis | protein farnesyltransferase alpha subunit | 0.0359 | 0.4575 | 0.4575 |
Giardia lamblia | Prenyltransferase | 0.0578 | 0.7809 | 1 |
Entamoeba histolytica | geranylgeranyl transferase beta subunit | 0.0343 | 0.4327 | 0.5542 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3669 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0142 | 0.1352 | 0.1352 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0578 | 0.7809 | 1 |
Brugia malayi | Ets-domain containing protein | 0.0071 | 0.0292 | 0.0292 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0146 | 0.1413 | 0.1413 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0244 | 0.2865 | 0.3332 |
Brugia malayi | Fli-1 protein | 0.0214 | 0.2421 | 0.2421 |
Mycobacterium leprae | conserved hypothetical protein | 0.0051 | 0 | 0.5 |
Giardia lamblia | Rab geranylgeranyltransferase | 0.0178 | 0.1887 | 0.2417 |
Schistosoma mansoni | gabp alpha | 0.0071 | 0.0292 | 0.0292 |
Mycobacterium ulcerans | hypothetical protein | 0.0051 | 0 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | peptidyl-glycine monooxygenase | 0.0725 | 1 | 1 |
Schistosoma mansoni | ets-related | 0.0214 | 0.2421 | 0.2421 |
Mycobacterium leprae | conserved hypothetical protein | 0.0051 | 0 | 0.5 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0578 | 0.7809 | 0.7809 |
Schistosoma mansoni | geranylgeranyl transferase type I beta subunit | 0.0343 | 0.4327 | 0.4327 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0071 | 0.0292 | 0.0292 |
Trypanosoma brucei | Protein prenyltransferase alpha subunit repeat, putative | 0.0244 | 0.2865 | 0.3332 |
Schistosoma mansoni | protein farnesyltransferase alpha subunit | 0.0359 | 0.4575 | 0.4575 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0244 | 0.2865 | 0.3332 |
Leishmania major | geranylgeranyltransferase, putative | 0.0178 | 0.1887 | 0.2417 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0244 | 0.2865 | 0.2865 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0244 | 0.2865 | 0.3332 |
Leishmania major | protein farnesyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3669 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0578 | 0.7809 | 0.9082 |
Echinococcus multilocularis | geranylgeranyl transferase type I beta subunit | 0.0343 | 0.4327 | 0.4327 |
Plasmodium vivax | prenyltransferase alpha subunit, putative | 0.0359 | 0.4575 | 0.5859 |
Mycobacterium ulcerans | hydrolase | 0.0051 | 0 | 0.5 |
Entamoeba histolytica | protein farnesyltransferase beta subunit, putative | 0.0578 | 0.7809 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 0.1887 | 0.1887 |
Echinococcus granulosus | geranylgeranyl transferase type I beta subunit | 0.0343 | 0.4327 | 0.4327 |
Mycobacterium ulcerans | beta lactamase-like protein | 0.0051 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | metallo-beta-lactamase superfamily hydrolase | 0.0051 | 0 | 0.5 |
Plasmodium vivax | geranylgeranyl transferase type2 beta subunit, putative | 0.0178 | 0.1887 | 0.2417 |
Mycobacterium tuberculosis | Halimadienyl diphosphate synthase | 0.0631 | 0.8598 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.019 | 0.2059 | 0.2059 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0195 | 0.2145 | 0.2145 |
Brugia malayi | Protein prenyltransferase alpha subunit repeat containing protein | 0.0359 | 0.4575 | 0.4575 |
Echinococcus granulosus | protein prenyltransferase alpha subunit | 0.0244 | 0.2865 | 0.2865 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit, putative | 0.0359 | 0.4575 | 0.5859 |
Schistosoma mansoni | dopamine-beta-monooxygenase | 0.0385 | 0.4958 | 0.4958 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0578 | 0.7809 | 1 |
Trypanosoma cruzi | geranylgeranyl transferase type II beta subunit, putative | 0.0178 | 0.1887 | 0.2195 |
Entamoeba histolytica | Rab geranylgeranyltransferase alpha subunit, putative | 0.0244 | 0.2865 | 0.3669 |
Giardia lamblia | Rab geranylgeranyltransferase | 0.0244 | 0.2865 | 0.3669 |
Chlamydia trachomatis | ribonuclease Z | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative | 0.0115 | 0.0957 | 0.1225 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0178 | 0.1887 | 0.2417 |
Trichomonas vaginalis | protein farnesyltransferase beta subunit, putative | 0.0178 | 0.1887 | 0.2417 |
Plasmodium falciparum | geranylgeranyl transferase type-2 subunit alpha, putative | 0.0244 | 0.2865 | 0.3669 |
Leishmania major | lanosterol synthase, putative | 0.0453 | 0.5957 | 0.7629 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0178 | 0.1887 | 0.2195 |
Schistosoma mansoni | geranylgeranyl transferase type II beta subunit | 0.0178 | 0.1887 | 0.1887 |
Mycobacterium leprae | POSSIBLE HYDROLASE | 0.0051 | 0 | 0.5 |
Plasmodium vivax | geranylgeranyltransferase, putative | 0.0178 | 0.1887 | 0.2417 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.014 | 0.014 |
Loa Loa (eye worm) | fli-1 protein | 0.0214 | 0.2421 | 0.2421 |
Trypanosoma brucei | lanosterol synthase | 0.0631 | 0.8598 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0385 | 0.4958 | 0.4958 |
Trypanosoma brucei | geranylgeranyl transferase type II beta subunit, putative | 0.0178 | 0.1887 | 0.2195 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.0578 | 0.7809 | 0.7809 |
Echinococcus multilocularis | geranylgeranyl transferase type 2 subunit alpha | 0.0244 | 0.2865 | 0.2865 |
Loa Loa (eye worm) | hypothetical protein | 0.0385 | 0.4958 | 0.4958 |
Loa Loa (eye worm) | hypothetical protein | 0.0725 | 1 | 1 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.0343 | 0.4327 | 0.4327 |
Trichomonas vaginalis | protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative | 0.0359 | 0.4575 | 0.5859 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 9.31 % | Antiinflammatory activity assessed as reduction of carrageenan-induced paw volume in intraperitonially dosed Wistar rat after 3 hrs | ChEMBL. | 17079151 |
Activity (functional) | = 4.1 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 4.1 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 15 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 4.1 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 4.1 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 15 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 4.48 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 30 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 4.48 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 30 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 4.56 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.56 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.6 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 15 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.6 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 15 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.63 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 30 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.63 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 30 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.67 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 60 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 4.67 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 60 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 5.72 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 120 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 5.72 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 120 mins by hot plate method | ChEMBL. | 17079151 |
Activity (functional) | = 5.89 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 60 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 5.89 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 60 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 5.93 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 120 mins by tail flick method | ChEMBL. | 17079151 |
Activity (functional) | = 5.93 s | Antinociceptive activity in ip dosed Swiss albino mouse assessed as latency time after 120 mins by tail flick method | ChEMBL. | 17079151 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.